Andrew John Geall

USPTO Granted Patents = 99 (Patent Applications = 57)

CIPO Patents = 4 (Patent Applications = 13)

EPO Patents = 34 (Patent Applications = 62)

Average Co-Inventor Count = 2.7

ph-index = 24

Forward Citations = 1,409(Granted Patents)

Forward Citations (Not Self Cited) = 855(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Del Mar, CA (US) (2008 - 2011)
San Marcos, CA (US) (2012 - 2014)
Littleton, MA (US) (2009 - 2024)
Cambridge, MA (US) (2012 - 2024)
Carlsbad, CA (US) (2019 - 2024)

Company Filing History:

53 out of 531

Glaxosmithkline Biologicals Sa

patents

24 out of 47

Avidity Biosciences, Inc.

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid-Polypeptide Compositions

RNA Delivery

Muscle Atrophy Treatment

Myotonic Dystrophy

Immunisation Techniques

Lipid Formulations

Immunogenic Compositions

RNA Purification Methods

Vaccine Development

Immune Pathway Activation

Pegylated Liposomes

Viral Immunogens

99 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12364769 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-22),

2. 12351637 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-08),

3. 12263224 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2025-04-01),

4. 12234290 - Nucleic acid-polypeptide compositions and uses thereof (2025-02-25),

5. 12186333 - Delivery of RNA to trigger multiple immune pathways (2025-01-07),

6. 12064483 - Nucleic acid-polypeptide compositions and methods of inducing exon skipping (2024-08-20),

7. 12018044 - RNA purification methods (2024-06-25),

8. 11913001 - Immunisation of large mammals with low doses of RNA (2024-02-27),

9. 11905514 - Immunisation of large mammals with low doses of RNA (2024-02-20),

10. 11896636 - Immunogenic combination compositions and uses thereof (2024-02-13),

11. 11891608 - Immunization of large mammals with low doses of RNA (2024-02-06),

12. 11883534 - Immunisation with lipid formulations with RNA encoding immunogens (2024-01-30),

13. 11872287 - Compositions and methods of treating muscle atrophy and myotonic dystrophy (2024-01-16),

14. 11865080 - Delivery of RNA to trigger multiple immune pathways (2024-01-09),

15. 11857681 - Lipid formulations with RNA encoding immunogens (2024-01-02),

Title: The Innovative Mind of Andrew John Geall

Introduction: Andrew John Geall, a talented inventor based in Carlsbad, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Andrew John Geall holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Andrew John Geall has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Andrew John Geall has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects. His collaborative spirit has led to the successful implementation of numerous groundbreaking ideas.

Conclusion: Andrew John Geall's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor in the field of technology. His contributions continue to inspire and shape the future of innovation worldwide.

This text is generated by artificial intelligence and may not be accurate.